Howard Doran served as our Chief Business Officer from September 2023 – April 2024. He has now assumed the role of President, with responsibility for global sales and marketing. Prior to joining Renalytix, he was President and Chief Executive Officer at LipoScience, where he stayed until its successful acquisition by LabCorp. Mr. Doran also served as President and Chief Operating Officer at Constitution Medical, Inc. and President of Hologic’s global diagnostics business. Earlier in his career, he was on the management team of Cytyc Corporation, holding a number of senior commercial roles, including physician sales and marketing, managed care, and laboratory sales and marketing. Mr. Doran received his B.S. degree in Management from West Chester University of Pennsylvania.